GO:1990350 glucose transporter complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990350 (glucose transporter complex) is a cellular component defined as a protein complex that facilitates glucose transport into, out of, or within a cell, or between cells.
• The complex is best understood through the GLUT/SLC2A family, especially GLUT4 in skeletal muscle and adipose tissue, where insulin and exercise regulate its translocation to the plasma membrane.
• GLUT1 and GLUT5 are also key members; GLUT1 supports basal glucose uptake in many tissues and is targeted in hypoxia-activated cancer therapy, while GLUT5 overexpression has tumorigenic implications.
• Complex formation can involve accessory proteins; the intracellular helical bundle of GLUT4 is important for complex formation with ASPL.
• Glucose transporter complexes are central to insulin resistance, exercise physiology, cancer metabolism, and hypoglycemia mitigation strategies.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal roles of glucose transporter complex components.
Description
The glucose transporter complex (GO:1990350) is a cellular component that facilitates glucose transport into, out of, or within a cell, or between cells. In practice, this term captures the protein assemblies built around facilitative glucose transporters, most prominently the SLC2A/GLUT family, which mediate the movement of glucose across membranes. Because glucose is a central fuel and signaling molecule, the composition and regulation of these complexes directly influence whole-body metabolic homeostasis. Researchers study GO:1990350 to understand how cells acquire glucose under basal, insulin-stimulated, and exercise-stimulated conditions, and how these processes go awry in disease. The complex is not a single static entity; it includes the transporter itself plus associated proteins that influence trafficking, stability, and function. For example, GLUT4-containing vesicles are mobilized to the plasma membrane in response to insulin and contractile activity in skeletal muscle. This dynamic behavior makes the glucose transporter complex a focal point for metabolic research, drug discovery, and CRISPR-based functional genomics.
glucose transporter complex At A Glance
| GO ID | GO:1990350 |
|---|---|
| GO term | glucose transporter complex |
| Ontology | cellular_component |
| Synonym | None |
| Definition | A protein complex facilitating glucose transport into, out of or within a cell, or between cells. |
| Major function | Facilitated glucose transport across membranes |
| Representative members | GLUT1 (SLC2A1), GLUT4 (SLC2A4), GLUT5 (SLC2A5), and associated proteins such as ASPL |
| Key regulators | Insulin signaling, contractile activity/exercise, AMPK-associated pathways |
| Disease relevance | Insulin resistance, cancer metabolism, hypoglycemia, and GLUT5-related tumorigenesis |
What Is GO:1990350?
According to the Gene Ontology, GO:1990350 (glucose transporter complex) is a protein complex that facilitates glucose transport into, out of, or within a cell, or between cells. In other words, it is an assembly of proteins whose collective function is to move glucose across biological membranes, either into the cytoplasm, out of the cell, or between cellular compartments. This definition emphasizes the complex as a functional unit rather than a single polypeptide, and it accommodates the diverse GLUT/SLC2A-containing assemblies that carry out facilitative glucose transport in different tissues.
Why Is glucose transporter complex Important in Cell Biology?
The glucose transporter complex is important because glucose uptake is a rate-limiting step for cellular metabolism, and its dysregulation underlies major human diseases. In skeletal muscle and adipose tissue, insulin and exercise stimulate GLUT4 translocation to the plasma membrane, a process that is impaired in insulin resistance and type 2 diabetes. In cancer, glucose transporter complexes, especially those containing GLUT1 and GLUT5, support the high glycolytic demand of tumor cells and are being explored as therapeutic targets. Moreover, engineered glucose transporter inhibitors can mitigate hypoglycemia, illustrating the translational value of understanding complex function. Accessory proteins such as ASPL can influence GLUT4 complex formation, adding another layer of regulation relevant to both physiology and disease.
• Controls rate-limiting glucose uptake in muscle, fat, and other tissues.
• Mediates insulin-stimulated and exercise-stimulated glucose disposal.
• Implicated in insulin resistance and type 2 diabetes.
• Supports tumor metabolism via GLUT1 and GLUT5.
• Provides targets for hypoglycemia mitigation strategies.
• Involves accessory proteins such as ASPL that modulate complex formation.
• Links to AMPK/PGC-1alpha signaling in skeletal muscle adaptation.
• Enables CRISPR-based dissection of causal metabolic genes.
• Serves as a model for membrane protein complex assembly and trafficking.
• Offers biomarkers and therapeutic opportunities in oncology.
What Happens During glucose transporter complex?
Glucose transport cycle
In simple terms: The complex binds glucose on one side of the membrane and releases it on the other side.
The glucose transporter complex facilitates the movement of glucose across cellular membranes. In skeletal muscle, GLUT4-containing complexes cycle between intracellular storage vesicles and the plasma membrane, allowing glucose to enter the cell when needed. This transport is not energy-dependent in the classical sense but is driven by glucose gradients and regulated by the availability of transporters at the membrane.
Insulin-stimulated translocation
In simple terms: Insulin acts like a signal that tells the cell to move glucose transporters to its surface.
Insulin signaling promotes the translocation of GLUT4-containing vesicles to the plasma membrane, increasing glucose uptake in muscle and adipose tissue. This process is a hallmark of postprandial glucose disposal and is defective in insulin-resistant states. The glucose transporter complex is therefore a dynamic assembly whose membrane residence is tightly controlled.
Exercise and contraction-stimulated uptake
In simple terms: Muscle contraction during exercise also moves glucose transporters to the cell surface, independent of insulin.
Contractile activity stimulates glucose uptake in skeletal muscle through mechanisms that can act independently of insulin, involving GLUT4 translocation and AMPK-associated signaling. This contraction-stimulated pathway is important for exercise performance and metabolic health. It also highlights that the glucose transporter complex responds to multiple physiological inputs.
Complex formation with accessory proteins
In simple terms: Other proteins can bind to the transporter and affect how the complex works.
The intracellular helical bundle of human GLUT4 is important for complex formation with ASPL, indicating that accessory proteins can directly associate with glucose transporters and potentially influence their function or trafficking. Such interactions expand the definition of the glucose transporter complex beyond the transporter alone. Understanding these assemblies may reveal new regulatory nodes.
Key Genes Involved in GO:1990350 glucose transporter complex
The following genes and proteins are central to the glucose transporter complex and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A4 (GLUT4) | Insulin- and exercise-responsive glucose transporter in muscle and fat | Key target for diabetes and exercise research |
| SLC2A1 (GLUT1) | Basal glucose uptake in many tissues; upregulated in cancer | Target for hypoxia-activated cancer therapy |
| SLC2A5 (GLUT5) | Fructose transporter; overexpressed in some tumors | Tumorigenic implications and cancer metabolism |
| ASPL | Accessory protein forming complex with GLUT4 | Modulates GLUT4 complex formation |
| AKT2 | Insulin signaling kinase promoting GLUT4 translocation | Insulin resistance mechanisms |
| PRKAA1/PRKAA2 (AMPK) | Energy sensor linked to contraction-stimulated glucose uptake | Exercise and metabolic regulation |
| PPARGC1A (PGC-1alpha) | Transcriptional coactivator phosphorylated by AMPK | Muscle adaptation and glucose uptake |
| INS | Insulin hormone controlling glucose transporter trafficking | Hypoglycemia and diabetes research |
| INSR | Insulin receptor initiating signaling to GLUT4 | Insulin resistance |
| TBC1D4 (AS160) | Rab GTPase-activating protein in GLUT4 trafficking | Insulin-stimulated glucose transport |
| RAB10 | Small GTPase involved in GLUT4 vesicle trafficking | Membrane trafficking of glucose transporters |
| SLC2A2 (GLUT2) | Bidirectional glucose transporter in liver and pancreas | Glucose sensing and metabolism |
| SLC2A3 (GLUT3) | Neuronal glucose transporter | Brain glucose metabolism |
| HIF1A | Hypoxia-inducible factor regulating GLUT1 expression | Cancer and hypoxia response |
| SLC2A6 (GLUT6) | Less characterized facilitative glucose transporter | Emerging metabolic roles |
| SLC2A8 (GLUT8) | Intracellular glucose transporter | Subcellular glucose transport |
| SLC2A12 (GLUT12) | Insulin-responsive glucose transporter | Muscle and adipose glucose uptake |
How Is glucose transporter complex Regulated?
The glucose transporter complex is regulated at multiple levels. Insulin signaling promotes GLUT4 translocation to the plasma membrane, while contractile activity and AMPK-associated pathways provide an insulin-independent route for increasing glucose uptake in skeletal muscle. AMPK can directly phosphorylate PGC-1alpha, linking energy stress to transcriptional adaptation. In cancer, hypoxia-inducible pathways can upregulate GLUT1, supporting glycolytic metabolism. Accessory proteins such as ASPL can also influence GLUT4 complex formation. Together, these layers of regulation ensure that glucose transport matches cellular energy demand and systemic metabolic state.
glucose transporter complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A4 (GLUT4) | Insulin resistance, type 2 diabetes | Knockout and knock-in models in muscle cells |
| SLC2A1 (GLUT1) | Cancer, hypoxia response | Overexpression and point-mutation models |
| SLC2A5 (GLUT5) | Tumorigenesis, fructose metabolism | Overexpression models |
| ASPL | GLUT4 complex formation | Knock-in and tagged knock-in models |
| PRKAA1/PRKAA2 (AMPK) | Exercise and metabolic regulation | Knockout models |
Insulin resistance and type 2 diabetes
Impaired GLUT4-mediated glucose transport is a central feature of insulin resistance, contributing to reduced glucose disposal in muscle and adipose tissue. Understanding the glucose transporter complex is therefore critical for developing strategies to restore insulin sensitivity.
Cancer metabolism
Many tumors upregulate glucose transporters such as GLUT1 and GLUT5 to meet high glycolytic demands. GLUT1-targeting and hypoxia-activated therapies are being explored to selectively attack cancer cells, while GLUT5 overexpression has been linked to tumorigenic implications.
Hypoglycemia and therapeutic targeting
Glucose transporter inhibitor-conjugated insulin has been designed to mitigate hypoglycemia, showing that modulating glucose transporter complex activity can have direct clinical benefit. This approach leverages the complex as a drug target.
Exercise and metabolic health
Contraction-stimulated glucose uptake via GLUT4 is important for exercise performance and metabolic health, and defects in this pathway are associated with metabolic disease. Studying the complex helps explain how physical activity improves glucose homeostasis.
From glucose transporter complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GLUT4 impair insulin-stimulated glucose uptake? | SLC2A4 knockout cell model |
| Does a specific GLUT1 mutation alter transport kinetics? | SLC2A1 point-mutation knock-in |
| How does ASPL binding affect GLUT4 complex assembly? | ASPL tagged knock-in |
| Does GLUT5 overexpression promote tumorigenic phenotypes? | SLC2A5 overexpression model |
| Can AMPK activation rescue contraction-stimulated uptake? | PRKAA1/PRKAA2 knockout with AMPK agonists |
| Does hypoxia increase GLUT1-dependent glucose uptake? | HIF1A overexpression or hypoxia chamber |
How to Study the glucose transporter complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 2-NBDG uptake assay | Glucose transport activity | Screening for regulators of glucose uptake |
| Subcellular fractionation | Transporter localization | GLUT4 translocation studies |
| Co-immunoprecipitation | Protein-protein interactions | Identifying accessory proteins like ASPL |
| Live-cell imaging | Dynamic trafficking of transporters | Real-time GLUT4 vesicle movement |
| CRISPR knockout screens | Gene requirement for glucose uptake | Functional genomics of metabolism |
| RNA-seq | Transcriptional changes in transporter genes | Hypoxia and insulin response |
| Western blot | Protein expression and phosphorylation | Insulin signaling and AMPK activation |
| Hypoxia chamber | Oxygen-dependent regulation | GLUT1-targeting cancer studies |
Glucose uptake assays
Radiolabeled or fluorescent glucose analogs are used to measure transport activity in cells expressing different glucose transporter complexes. These assays are foundational for linking complex composition to function.
Membrane fractionation and imaging
Subcellular fractionation and immunofluorescence can track GLUT4 translocation from intracellular vesicles to the plasma membrane. Live-cell imaging of tagged transporters provides dynamic information about complex trafficking.
Proteomics and interaction studies
Co-immunoprecipitation and mass spectrometry can identify accessory proteins that associate with glucose transporters, such as ASPL with GLUT4. These approaches help define the full composition of the glucose transporter complex.
CRISPR screening and functional genomics
Pooled CRISPR screens can identify genes that regulate glucose uptake or transporter trafficking, providing unbiased insights into the complex. Such screens are increasingly used in metabolic research.
How CRISPR Can Be Used to Study GO:1990350 glucose transporter complex
Knockout
CRISPR knockout of SLC2A4 or other glucose transporter genes can abolish specific transport activities, allowing researchers to test causality in glucose uptake and metabolism. Knockout models are also useful for validating drug targets.
Point Mutation
Introducing point mutations into transporter genes can reveal residues critical for substrate binding, trafficking, or complex formation. For example, mutations in the intracellular helical bundle of GLUT4 can disrupt ASPL binding.
Knock-in
Knock-in of tagged transporters (e.g., GFP-GLUT4) enables live-cell imaging and proteomic isolation of the complex. This approach helps define the dynamic composition of the glucose transporter complex.
Overexpression
Overexpression of GLUT1 or GLUT5 can model cancer-associated metabolic reprogramming and test therapeutic vulnerabilities. Overexpression models are also used to study hypoxia-driven glucose uptake.
How EDITGENE Supports glucose transporter complex Research
Researchers studying glucose transporter complex-related genes often need to determine whether a candidate gene is causally involved in glucose transport, trafficking, or metabolic disease. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for glucose transporter complex research.
Frequently Asked Questions About glucose transporter complex
What is GO:1990350 glucose transporter complex?
GO:1990350 is a Gene Ontology cellular component term describing a protein complex that facilitates glucose transport into, out of, or within a cell, or between cells.
What genes are involved in the glucose transporter complex?
Key genes include SLC2A4 (GLUT4), SLC2A1 (GLUT1), SLC2A5 (GLUT5), and accessory proteins such as ASPL.
How is the glucose transporter complex regulated?
It is regulated by insulin signaling, muscle contraction/exercise, AMPK-associated pathways, and hypoxia-inducible factors.
What diseases are linked to glucose transporter complex dysfunction?
Insulin resistance, type 2 diabetes, cancer metabolism, and hypoglycemia are linked to glucose transporter complex dysfunction.
How can I study glucose transporter complex in the lab?
Common methods include glucose uptake assays, subcellular fractionation, imaging, proteomics, and CRISPR screens.
What is the role of GLUT4 in glucose transport?
GLUT4 is an insulin- and exercise-responsive transporter that translocates to the plasma membrane to increase glucose uptake in muscle and fat.
Can CRISPR be used to study glucose transporter complex?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect glucose transporter complex function.
What is the difference between GLUT1 and GLUT5?
GLUT1 primarily supports basal glucose uptake and is upregulated in cancer, while GLUT5 transports fructose and has tumorigenic implications when overexpressed.
How does exercise affect the glucose transporter complex?
Exercise stimulates GLUT4 translocation to the plasma membrane, increasing glucose uptake independently of insulin.
What experimental models are available for glucose transporter complex research?
Models include knockout, point-mutation, knock-in, tagged knock-in, and overexpression cell lines, as well as CRISPR library screens.
Conclusion
The glucose transporter complex (GO:1990350) is a dynamic protein assembly that controls glucose flux into, out of, and within cells. Its best-characterized members, including GLUT4, GLUT1, and GLUT5, are regulated by insulin, exercise, and hypoxia, and are implicated in diabetes, cancer, and hypoglycemia. Accessory proteins such as ASPL further modulate complex formation, highlighting the complexity of these assemblies. CRISPR-based models are powerful tools for dissecting the causal roles of individual components and for identifying new therapeutic targets.
References
- 1. Herman R et al.. 2022. Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport.. Int J Mol Sci 23(3) PMID: 35163187
- 2. Richter EA et al.. 2013. Exercise, GLUT4, and skeletal muscle glucose uptake.. Physiol Rev 93(3):993-1017 PMID: 23899560
- 3. Richter EA et al.. 2025. A comprehensive view of muscle glucose uptake: regulation by insulin, contractile activity, and exercise.. Physiol Rev 105(3):1867-1945 PMID: 40173020
- 4. Hadzi-Petrushev N et al.. 2024. GLUT5-overexpression-related tumorigenic implications.. Mol Med 30(1):114 PMID: 39107723
- 5. Wang J et al.. 2019. Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia.. Proc Natl Acad Sci U S A 116(22):10744-10748 PMID: 31097579
- 6. Jäger S et al.. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha.. Proc Natl Acad Sci U S A 104(29):12017-22 PMID: 17609368
- 7. Huang P et al.. 2023. The intracellular helical bundle of human glucose transporter GLUT4 is important for complex formation with ASPL.. FEBS Open Bio 13(11):2094-2107 PMID: 37731227
- 8. Wei G et al.. 2022. Glucose transporter 1 (GLUT1)-targeting and hypoxia-activated mitochondria-specific chemo-thermal therapy via a glycosylated poly(amido amine)/celastrol (PAMAM/Cel) complex.. J Colloid Interface Sci 608(Pt 2):1355-1365 PMID: 34742058
